A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis

Oral Oncology

Volumn 38, Issue 4, 2002, Pages 337-342

  Lefebvre, Jean Louis ^a   Domenge, Christian ^b  

^a Oscar Lambret Centre   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Amphotericin B; Comparative study; Fluconazole; Head and neck neoplasms; Oral candidiasis; Suspension

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADULT; AGED; ARTICLE; ASTHENIA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANDIDA ALBICANS; CHEMOTHERAPY INDUCED EMESIS; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHAGIA; ERYTHEMA; FEMALE; FUNGUS CULTURE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN INFLAMMATION; THRUSH; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; FEMALE; FLUCONAZOLE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; STOMATITIS; TREATMENT OUTCOME;

EID: 0036078522     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(01)00063-X     Document Type: Article

References (23)

1. Oral candidiasis
2. Oropharyngeal candidiasis: A review of its clinical spectrum and current therapies
3. Oral candidiasis
4. Treatment of oral Candida mucositis infections
5. Oropharyngeal and esophageal candidiasis in immunocompromised patients: Treatment issues
6. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidasis in patients infected with human immunodeficiency virus
7. Oropharyngeal candidiasis in patients with HIV: Suggested guidelines for therapy
8. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection
9. Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules
10. Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: Studies with a suspension
11. Salivary concentrations of ketoconazole and fluconazole: Implications for drug efficacy in oropharyngeal and esophageal candidiasis
12. Pharmacokinetics and tissue penetration of fluconazole in humans
13. Comparison of fluconazole and ketoconazole for oropharyngeal candidasis in AIDS
14. Overview of studies with fluconazole in oropharyngeal candidiasis
15. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children
16. Therapy for oropharyngeal candidiasis in the immunocompromised host: A randomized double-blind study of fluconazole vs. ketoconazole
17. Therapy for oropharyngeal candidasis in HIV-infected patients: A randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches
18. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis
19. Oropharyngeal candidiasis in immunocompromised children: A randomized multicenter study of orally administered fluconazole suspension versus nystatin
20. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidiosis
21. Prospective study of fluconazole suspension for the treatment of oesophageal candidasis in patients with AIDS
22. Fluconazole suspension for oropharyngeal candidasis unresponsive to tablets [letter]
23. Oropharyngeal candidiasis in patients with AIDS: Randomized comparison of fluconazole versus nystatin oral suspension